BioCentury | Feb 9, 2015
Company News

Chinese Academy of Sciences, MicroConstants China deal

MicroConstants received worldwide rights from the academy’s Institute of Biophysics to develop and commercialize antibody AA98 to treat cancer, multiple sclerosis (MS) and age-related macular degeneration (AMD). The academy is eligible to receive more than...
Items per page:
1 - 1 of 1